🔒
Price chart and 15 days of daily prices
Candlestick chart with moving averages, Bollinger bands and MACD.
Register free to view.
Security Profile
- Security Type
- Common Stock
- CUSIP
- 03237H101
- Market Cap
- Large Cap
- IPO
- 1/6/2022 · $19.00/share
Business: Amylyx Pharmaceuticals, Inc. is a clinical-stage pharmaceutical company working on developing a novel therapeutic for amyotrophic lateral sclerosis (ALS) and other neurodegenerative diseases.
Company Contact
- CEO
- Josh Cohen
- CFO
- James M. Frates
- Headquarters
- 43 Thorndike St., Cambridge, MA 02141
- Phone
- 617-682-0917
- Investor Relations
- James Frates · 857-320-6230 · Jim_Frates@amylyx.com